Early Phase Clinical Trial Units

早期临床试验单位

• 批准号: 10788042
• 负责人: GEORGE SAVIOLAKIS
• 金额: $ 20.88万
• 依托单位: DYNPORT VACCINE COMPANY, LLC
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-01-14 至 2024-01-13
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10788042
• 关键词: Clinical Trials; Clinical Trials Unit; Communicable Diseases; Development; Intervention; Investigation; National Institute of Allergy and Infectious Disease; New Agents; Prevention; clinical trial implementation; early phase clinical trial

The Early Phase Clinical Trial Units provide a vehicle for investigation of new agents in the treatment and prevention of infectious diseases, and can carry out all aspects of interventional clinical trial implementation.

早期临床试验单位为传染病治疗和预防方面的新药研究提供了载体，可以开展介入性临床试验实施的各个环节。